强直性脊柱炎患者吸烟状态与疾病严重程度及生活质量的关系:苏格兰登记研究
基于苏格兰强直性脊柱炎登记库946例临床诊断脊柱关节炎患者,分析吸烟、戒烟与疾病特征及生活质量的关系。结果显示曾吸烟者BASDAI、BASFI更差且ASQoL更差;与当前吸烟者相比,戒烟者疾病活动度更低、生活质量更好,且葡萄膜炎史更常见。
要点
- 曾吸烟者较从不吸烟者BASDAI β=0.5、BASFI β=0.8、ASQoL β=1.5,均更差。
- 与当前吸烟者相比,戒烟者BASDAI β=-0.5、ASQoL β=-1.2,疾病活动度更低且生活质量更好。
- 戒烟者葡萄膜炎史OR 2.4(95%CI 1.5, 3.8),提示临床应促进戒烟。
核心结论
- 脊柱关节炎吸烟者疾病严重程度高于从不吸烟者。
- 在吸烟者中,戒烟与更低的疾病活动度、更好的躯体功能和生活质量相关。
- 临床应将促进戒烟作为脊柱关节炎常规治疗的辅助措施。
研究设计与样本
- 苏格兰强直性脊柱炎登记库纳入946例临床诊断脊柱关节炎患者,收集病历中BASDAI、BASFI及邮寄问卷中吸烟状态和ASQoL数据。
- 采用线性与逻辑回归量化吸烟及戒烟对疾病特异性和生活质量结局的影响,调整年龄、性别、贫困程度、教育水平和饮酒。
- 结果以回归系数(β)或比值比(OR)及95%置信区间(95%CI)呈现。
主要发现
- 946例参与者中73.5%为男性,平均年龄52岁;当前吸烟者占22%,戒烟者占38%。
- 曾吸烟者BASDAI β=0.5(95%CI 0.2, 0.9)、BASFI β=0.8(95%CI 0.4, 1.2)、ASQoL β=1.5(95%CI 0.7, 2.3),均差于从不吸烟者。
- 与当前吸烟者相比,戒烟者BASDAI β=-0.5(95%CI -1.0, -0.04)、ASQoL β=-1.2(95%CI -2.3, -0.2),疾病活动度更低且生活质量更好。
- 戒烟者较当前吸烟者更可能有葡萄膜炎史,OR 2.4(95%CI 1.5, 3.8)。
临床怎么用
- 临床应针对脊柱关节炎患者特别促进戒烟,作为常规治疗的辅助措施。
- 评估吸烟状态有助于识别疾病活动度和生活质量更差的患者群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the relationship between smoking, smoking cessation, and disease characteristics and quality of life (QoL) in spondyloarthritis. METHODS: The Scotland Registry for Ankylosing Spondylitis collects data from clinically diagnosed patients with spondyloarthritis. Clinical data, including Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) scores, were obtained from medical records. Mailed questionnaires contained information on smoking status and QoL (Ankylosing Spondylitis QoL questionnaire [ASQoL]). Linear and logistic regression were used to quantify the effect of smoking, and smoking cessation, on various disease-specific and QoL outcomes, with adjustments for age, sex, deprivation, education level, and alcohol use. Results are presented as regression coefficients (β) or odds ratios (ORs) with 95% confidence intervals (95% CIs). RESULTS: Data were obtained from 946 participants (73.5% male, mean age 52 years). Current smoking was reported by 22%, and 38% were ex-smokers. Ever smokers had poorer BASDAI (β = 0.5 [95% CI 0.2, 0.9]) and BASFI scores (β = 0.8 [95% CI 0.4, 1.2]), and reported worse QoL (ASQoL β = 1.5 [95% CI 0.7, 2.3]). Compared to current smokers, ex-smokers reported less disease activity (BASDAI β = -0.5 [95% CI -1.0, -0.04]) and significantly better QoL (ASQoL β = -1.2 [95% CI -2.3, -0.2]). They also were more likely to have a history of uveitis (OR 2.4 [95% CI 1.5, 3.8]). CONCLUSION: Smokers with spondyloarthritis experience worse disease than those who are never smokers. However, this study provides new evidence that, among smokers, smoking cessation is associated with lower disease activity and better physical function and QoL. Clinicians should specifically promote smoking cessation as an adjunct to usual therapy in patients with spondyloarthritis.
引用
- Jones GT, Ratz T, Dean LE, et al. Disease Severity in Never Smokers, Ex-Smokers, and Current Smokers With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2017. PMID: 27899002. doi:10.1002/acr.23157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。